1)Norgren L, et al:Inter-society consensus for the management of peripheral arterial disease(TASCⅡ). Eur J Vasc Endovasc Surg 33:S1-S75, 2007
2)Dormandy JA, et al:Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study(PROspective pioglitAzone Clinical Trial In macroVascular Events):a randomised controlled trial. Lancet 366:1279-1289, 2005
3)宮本正章,他:治療抵抗性末梢動脈疾患(Pad)に対する再生医療を応用した先進併用療法.日医大医会誌5:33-37,2009
4)星野純一,他:閉塞性動脈硬化症(ASO)への治療法と四肢機能.日透析医会誌41:50-53,2008
5)Chin T, et al:%VO2max as an indicator of prostheticrehabilitation outcome after dysvascularamputation. Prosthet Orthot Int 26:44-49, 2002
6)Criqui MH, et al:Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 326:381-386, 1992
7)Willigendael EM, et al:Smoking and the patency of lower extremity bypass grafts:a meta-analysis. J vasc surg 42:67-74, 2005
8)American Diabetes Association:Standards of medical care in diabetes-2006. Diabetes Care 29:S4-42, 2006
9)Demling RH. Nutrition, anabolism, and the wound healing process:an overview. Eplasty 9:e9, 2009
10)Lee JK, et al:Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol:a randomized controlled trial. JAMA 296:2563-2571, 2006
11)Gehi AK, et al:Whooley MA. Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease:the heart and soul study. Arch Intern Med 167:1798-1803, 2007
12)Iwai T, et al:Oral bacteria in the occluded arteries of patients with Buerger disease. J vasc surg 42:107-115, 2005
13)Taylor RS, et al:Exercise-based rehabilitation for patients with coronary heart disease:systemic review and meta-analysis of randomized controlled trials. Am J Med 116:682-692, 2004